BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
126 results:

  • 1. Novel MED15::atf1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation.
    Furtado LV; Cardenas M; Santiago T; Ruiz RE; Shi Z; Pappo A; Kacar M
    Genes Chromosomes Cancer; 2024 Mar; 63(3):e23230. PubMed ID: 38459940
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MED15::atf1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
    Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
    Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Malignant gastrointestinal neuroectodermal tumor: a clinicopathological analysis of three cases].
    Fan CY; Wang YX; Hu PZ; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):791-796. PubMed ID: 37527982
    [No Abstract]    [Full Text] [Related]  

  • 4. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.
    Alexandrescu S; Imamovic-Tuco A; Janeway K; Hanna J
    J Cutan Pathol; 2023 Jul; 50(7):619-622. PubMed ID: 37057373
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
    Rasmussen SV; Wozniak A; Lathara M; Goldenberg JM; Samudio BM; Bickford LR; Nagamori K; Wright H; Woods AD; Chauhan S; Lee CJ; Rudzinski ER; Swift MK; Kondo T; Fisher DE; Imyanitov E; Machado I; Llombart-Bosch A; Andrulis IL; Gokgoz N; Wunder J; Mirotaki H; Nakamura T; Srinivasa G; Thway K; Jones RL; Huang PH; Berlow NE; Schöffski P; Keller C
    Br J Cancer; 2023 May; 128(10):1941-1954. PubMed ID: 36959380
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary Clear Cell Sarcoma of Bone: Clinicopathologic Study of a Rare Presentation.
    Odintsov I; Jagannathan JP; Al-Ibraheemi A; Selig MK; Newman ET; Fletcher CDM; Nielsen GP; Hornick JL
    Am J Surg Pathol; 2023 Mar; 47(3):354-360. PubMed ID: 36730915
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study.
    Kushnir-Grinbaum D; Krausz J; Rahal N; Apel-Sarid L; Ziv M
    Acta Derm Venereol; 2023 Jan; 103():adv00841. PubMed ID: 36600530
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
    Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
    Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines.
    Ishiguro M; Fukushige T; Iwasaki H; Hamasaki M
    Anticancer Res; 2022 Nov; 42(11):5315-5322. PubMed ID: 36288876
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.
    Patel TH; Marcus L; Horiba MN; Donoghue M; Chatterjee S; Mishra-Kalyani PS; Schuck RN; Li Y; Zhang X; Fourie Zirkelbach J; Charlab R; Liu J; Yang Y; Lemery SJ; Pazdur R; Theoret MR; Fashoyin-Aje LA
    Clin Cancer Res; 2023 Mar; 29(5):838-842. PubMed ID: 36206041
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The prevalence of skin lesions and associated factors in hospitalised adult patients with cancer.
    de Castro DLV; da Silva EL; Onaga LS; Nogueira PC; Furlan PC; de Gouveia Santos VLC
    J Wound Care; 2022 Aug; 31(8):660-668. PubMed ID: 36001701
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Malignant gastrointestinal neuroectodermal tumor in head and neck: two challenging cases with diverse morphology and different considerations for differential diagnosis.
    Kuo CT; Kao YC; Huang HY; Hsiao CH; Lee JC
    Virchows Arch; 2022 Jul; 481(1):131-136. PubMed ID: 35039897
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The effect of combined TPF and intensity modulated radiotherapy after TPF induction chemotherapy on locally advanced nasopharyngeal carcinoma: a retrospective analysis.
    Zheng L; Xu Q; Yang Z; Bei Y; Tong J; Ye S; Hu J; Chen X; Lv J
    Ann Palliat Med; 2021 Sep; 10(9):9669-9677. PubMed ID: 34628892
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Malignant gastrointestinal neuroectodermal tumor: Cytologic, histologic, immunohistochemical, and molecular pitfalls.
    Sivasubramaniam P; Tiegs-Heiden CA; Sturgis CD; Hagen CE; Hartley CP; Thangaiah JJ
    Ann Diagn Pathol; 2021 Dec; 55():151813. PubMed ID: 34509898
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.
    Gu L; Peng C; Zhang F; Fang C; Guo G
    Orphanet J Rare Dis; 2021 Jun; 16(1):277. PubMed ID: 34127034
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Leckey BD; John I; Reyes-Múgica M; Naous R
    Pediatr Dev Pathol; 2021; 24(3):258-263. PubMed ID: 33683984
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Body Mass Index and 90-Day Mortality Among 35,406 Danish Patients Hospitalized for Infection.
    Gribsholt SB; Pedersen L; Richelsen B; Sørensen HT; Thomsen RW
    Mayo Clin Proc; 2021 Mar; 96(3):550-562. PubMed ID: 33673909
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary clear cell sarcoma of the femur: a unique case with RT-PCR and direct sequencing confirmation of EWSR1/atf1 fusion gene.
    Kubota Y; Tanaka K; Hisaoka M; Daa T; Iwasaki T; Kawano M; Itonaga I; Tsumura H
    BMC Musculoskelet Disord; 2021 Jan; 22(1):99. PubMed ID: 33478436
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. EIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY.
    Eandi CM; Polito MS; Schalenbourg A; Zografos L
    Retina; 2021 Sep; 41(9):1883-1891. PubMed ID: 33411473
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
    Uemura H; Arai G; Uemura H; Suzuki H; Iijima K; Nishimura K; Fujii K; Hatayama T; Aoyama J; Deprince K; Lopez-Gitlitz A; McCarthy S; Larsen JS; Li J; Chi KN
    Int J Urol; 2021 Mar; 28(3):280-287. PubMed ID: 33295007
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.